Abstract
Diltiazem is a calcium channel blocker commonly used in the treatment of various cardiovascular disorders such as hypertension, angina and supraventricular tachycardias. Metabolism occurs mainly in the liver, but a small percentage of unchanged drug and metabolites are excreted in the urine. Toxicity from this medication usually presents in the form of dysrrhytmias and heart block. Hence, we present a case of complete atrioventricular AV block in a patient receiving sustained- release diltiazem on a chronic basis. Risk factors such as advanced age and impaired renal function are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 23-27 |
Number of pages | 5 |
Journal | Open Cardiovascular Medicine Journal |
Volume | 7 |
Issue number | 1 |
DOIs | |
State | Published - 2013 |
Keywords
- AV block
- Diltiazem
- Renal failure
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine